Obama targets prescription drugs shortages

US President Barack Obama signed an executive order Monday directing action to head off shortages in life-saving prescription drugs, in his latest bid to bypass gridlock in Congress.

Obama's order strengthens the Federal Drug Administration's power to predict and tackle potential shortages of prescription drugs and to halt illegal price gouging of life-saving medicines during supply shortfalls.

"The shortage of prescription drugs drives up costs, leaves consumers vulnerable to price gouging and threatens our health and safety," said Obama said as he signed the order in the Oval Office.

"This is a problem we can't wait to fix. That's why today, I am directing my administration to take steps to protect consumers from .

"I'm committed to working with Congress and industry to keep tackling this problem going forward."

The president signed the order at his desk flanked by Bonnie Frawley, a pharmacy manager from Boston who regularly deals with drugs shortages and Jay Cuetara, a who was a victim of drugs shortages.

The FDA says the number of shortages of nearly tripled between 2005 and 2010.

Obama, in a campaign entitled "We Can't Wait" has flexed the executive powers of the presidency several times in recent weeks, in an effort to show Americans he is serious about creating jobs and easing their problems.

"Congress has been trying since February to do something about this. It has not yet been able to get it done, and it is the belief of this administration, as well as folks like Bonnie and Jay, that we can't wait for action," Obama said.

"We have got to go ahead and move forward."

Obama's recent moves include offering help to certain homeowners who are underwater in their mortgages and an effort to reduce the burden faced by graduates saddled with costly student loans.

add to favorites email to friend print save as pdf

Related Stories

Fear in US as drug shortages mount

Sep 04, 2011

Shortages of vital drugs, particularly cancer-fighting medication, have raised concerns in the United States, where regulators often have to race to try to find replacements.

FDA cracks down on untested cold medicines

Mar 02, 2011

(AP) -- The Food and Drug Administration says it will remove roughly 500 unapproved cold and allergy medications from the market as part of an ongoing campaign cracking down on ineffective prescription medications.

US lawmakers reject Canada drug purchases

Oct 20, 2011

The US Senate Thursday rejected a measure that would have enabled Americans to buy prescription drugs in Canada in a bid to reduce the costs of their health care.

Recommended for you

FDA OKs Cubist antibiotic for serious infections

5 hours ago

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.